Randomised, double-blind, placebo-controlled
Randomised controlled evidence for violet output
Violet laser output was assessed against a sham protocol for inflammatory skin presentations with blinded lesion counting.
Reported outcome. Significant reduction against sham was reported on the primary endpoint, with no thermal adverse events.








